Increased Camptothecin Toxicity Induced in Mammalian Cells Expressing Saccharomyces cerevisiae DNA Topoisomerase I
Open Access
- 1 April 1998
- journal article
- Published by Elsevier BV
- Vol. 273 (14), 8425-8433
- https://doi.org/10.1074/jbc.273.14.8425
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Alterations in the Catalytic Activity of Yeast DNA Topoisomerase I Result in Cell Cycle Arrest and Cell DeathPublished by Elsevier BV ,1997
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1996
- Topoisomerase Poisons: Harnessing the Dark Side of Enzyme MechanismJournal of Biological Chemistry, 1995
- A Camptothecin-resistant DNA Topoisomerase I Mutant Exhibits Altered Sensitivities to Other DNA Topoisomerase PoisonsPublished by Elsevier BV ,1995
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- YeastSaccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecinCancer Chemotherapy and Pharmacology, 1994
- DNA topoisomerase I is involved in both repression and activation of transcriptionNature, 1993
- DNA topoisomerases: Current Opinion in Structural Biology 1991, 1:99–103Current Opinion in Structural Biology, 1991
- DNA topoisomerase-targeting antitumor drugs can be studied in yeast.Proceedings of the National Academy of Sciences, 1988
- Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication forks.Molecular and Cellular Biology, 1988